Holdings of GSK plc
11 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 99.3 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 72.5 %
- DE 25.2 %
- GB 2.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 9 | 227.5M $ | 72.52 % |
| 2 | DE | 1 | 79.1M $ | 25.21 % |
| 3 | GB | 1 | 7.1M $ | 2.26 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | BioNTech SE | 889,824 | 79.1M $ | |
| 2 | Vir Biotechnology Inc | 8,550,954 | 76.6M $ | |
| 3 | Ideaya Biosciences Inc | 1,333,333 | 44.4M $ | |
| 4 | Lyell Immunopharma Inc | 1,512,659 | 30.3M $ | |
| 5 | Cytokinetics Inc | 340,434 | 22.4M $ | |
| 6 | Spero Therapeutics Inc | 9,190,606 | 21.5M $ | |
| 7 | Fulcrum Therapeutics Inc | 1,785,714 | 13.7M $ | |
| 8 | CVRx Inc | 1,007,583 | 9.5M $ | |
| 9 | Bicycle Therapeutics PLC | 1,529,561 | 7.1M $ | |
| 10 | Nkarta Inc | 3,150,732 | 6.6M $ | |
| 11 | REGENXBIO Inc | 271,456 | 2.3M $ |